Noven Pharmaceuticals focuses on the development, manufacture and sale of prescription pharmaceutical products in the United States. The company’s products focus on women’s health, as well as central nervous system disorders, including attention deficit hyperactivity disorder (ADHD). Noven’s commercialized transdermal products include Minivelle, Daytrana and CombiPatch. The company was founded in 1987 and is based in Miami, Florida. Noven are a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co.